Syndax Pharmaceuticals Down Over 17%, On Pace for Largest Percent Decrease Since May 2025 -- Data Talk
Dow Jones2026/10/13 14:49Syndax Pharmaceuticals Inc. (SNDX) is currently at $13.61, down $2.94 or 17.76%
--Would be lowest close since Oct. 30, 2025, when it closed at $13.39
--On pace for largest percent decrease since May 6, 2025, when it fell 21.59%
--Currently down five of the past six days
--Currently down two consecutive days; down 19.89% over this period
--Worst two day stretch since the two days ending May 7, 2025, when it fell 26.38%
--Down 27.6% month-to-date
--Down 35.21% year-to-date; on pace for worst year since 2024, when it fell 38.82%
--Down 53.03% from its all-time closing high of $28.98 on Feb. 1, 2023
--Down 11.09% from 52 weeks ago (Oct. 14, 2025), when it closed at $15.31
--Down 45.88% from its 52-week closing high of $25.15 on April 2, 2026
--Up 3.83% from its 52-week closing low of $13.11 on Oct. 27, 2025
--Traded as low as $13.49; lowest intraday level since Nov. 4, 2025, when it hit $13.15
--Down 18.49% at today's intraday low; largest intraday percent decrease since May 6, 2025, when it fell as much as 22.66%
All data as of 10:43:39 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 13, 2026 10:49 ET (14:49 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

SpaceX plans to issue $6 billion in bonds on Thursday, completing its total $32 billion bond financing to purchase Nvidia chips.
According to media reports, the current offering includes approximately $6 billion in bonds, increased from the previous $4 billion, and was opened to investors for subscription on Thursday. The remaining approximately $26 billion in notes have already been allocated. The funds will be used by a special purpose vehicle called Saturn Funding Trust to purchase NVIDIA AI chips, which SpaceX will initially use under a five-year lease agreement.

Hunterbrook short-selling report strikes AMD! Claims of wash trading and promised scale far exceeding Nvidia, AMD denies allegations
Hunterbrook Capital stated that AMD provides financing and guarantees to companies purchasing its chips, with the committed scale already far surpassing Nvidia, yet its cash reserves are relatively insufficient. The report also pointed out that some of the product lines AMD relies on for growth may face strict export controls. AMD responded by stating that the Hunterbrook report misrepresented AMD's business practices and partnerships. After the report was released, AMD experienced an intraday drop of up to 11%.

Bloomberg Economists: Anthropic's IPO May Signal the End of the AI Boom
Bloomberg economist Anna Wong believes that Anthropic's actual price per million tokens has dropped significantly since September. Although token usage has surged, its market share has actually declined, indicating that its technological edge has not translated into lasting pricing power. An IPO would bring the pricing and profit margins of cutting-edge AI into the public market for quarterly scrutiny; if its pricing power is weaker than what is implied by its valuation, the AI sector might see an accelerated correction in valuations.